Evolution Devices

Enhancing human movement with digital therapy and 3D biomechanics
Overview
Raised: $149,548
Rolling Commitments ($USD)
09/30/2023
$2,452
154
2017
Healthcare & Pharmaceuticals
HealthTech
B2B/B2C
Medium
Low
Summary Profit and Loss Statement
FY 2022 | FY 2021 | |
---|---|---|
Revenue |
$1,832 |
$0 |
COGS |
$872 |
$0 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-351,691 |
$-238,656 |
Summary Balance Sheet
FY 2022 | FY 2021 | |
---|---|---|
Cash |
$260,447 |
$98,779 |
Accounts Receivable |
$1,933 |
$101 |
Total Assets |
$268,173 |
$105,072 |
Short-Term Debt |
$203,068 |
$18,567 |
Long-Term Debt |
$751,746 |
$421,454 |
Total Liabilities |
$954,814 |
$440,021 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual